Drug intelligence / Profile preview

spirulina platensis extract

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral, Topical
01

Overview

**Spirulina platensis extract** is a concentrated preparation derived from the cyanobacterium *Arthrospira platensis* (syn. *Spirulina platensis*), commonly marketed as a dietary supplement and functional food ingredient[1][2][6]. It is notable for its exceptionally high protein content (up to 60%), rich profile of essential amino acids, vitamins (notably B12), minerals, polyunsaturated fatty acids (γ-linolenic acid), phycocyanin, carotenoids (β-carotene), polysaccharides (including calcium spirulan), and other antioxidant pigments[2][4][6]. \n**Mechanism of Action:** The extract exhibits several biological activities, mostly attributed to its bioactive compounds: \n- **Phycocyanin** and other pigments provide antioxidant, anti-inflammatory, immunomodulatory, and anti-cancer effects through inhibition of pro-inflammatory cytokines (e.g., COX-2 inhibition), induction of apoptosis, and scavenging free radicals[2][5][6].\n- **Polysaccharides (e.g., calcium spirulan)** display antiviral activities by inhibiting viral replication and entry[5][6]. \n- **γ-linolenic acid** and related lipids contribute to lipid-lowering and antidiabetic action[4][6]. \n- Additional compounds exert antihypertensive, antimicrobial, and neuroprotective effects through diverse mechanisms[3][6][7]. \n**Primary indications:** Investigated as a nutraceutical for chronic arsenic poisoning (with zinc)[5], metabolic syndrome, diabetes, hyperlipidemia, antioxidant supplementation, and potentially neurodegenerative diseases such as Alzheimer's and Parkinson's[7]. \nMost claims remain under investigation; spirulina platensis extract is primarily used as a dietary supplement.

Brand names
Apogen
Other names
spirulina platensisArthrospira platensis extractS. platensis extractspirulina extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)CDKN1A (Cyclin-dependent kinase inhibitor 1A)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on spirulina platensis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on spirulina platensis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call